Methods
A retrospective analysis of the medical records and histological reports of patients with oral and maxillofacial tumors, cysts and tumor-like lesions who presented to the Maxillofacial Unit of University of Calabar Teaching Hospital from January 1997 to December 2007, a period of 11 years, was undertaken. Information on demographics, histological diagnosis and clinical presentation were obtained. The 2005 WHO criteria 11 were adopted for the classification of odontogenic tumors and cyst of the jaws. The age limit for categorizations of tumor occurrence into pediatric or adult type was 19 years which is similar to that adopted by Aregbesola et al. 3 The collected data were analyzed and a p value of less than 0.05 was considered significant.
Results
A total of 146 patients, aged 5-70 years (mean 30.5+ 12.9) were seen over the period of study. There were 96 males (65.8%) and 50 females (34.2%) giving a male to female ratio of almost 2:1.There was no gender difference in terms of age (p>0.05). Benign tumors accounted for 124, 86.3% and malignant tumors (22, 13 .7%). Ameloblastoma was the most prevalent tumor observed 53 (36.3%) representing 80.3% of the 66 odontogenic tumors (OT). The other OT included keratocystic odontogenic tumor 12 (8.2%) and adenomatoid odontogenic tumor 1 (0.7%). Other lesions include non-odontogenic tumors mainly represented by pyogenic granuloma 11 (7.5%) and giant cell granuloma 4 (2.7%); fibro-osseous lesions 19 (13.0%), jaw cysts 20 ( 13.8%) and pleomorphic adenoma presenting as parotid swelling (1.4%). Malignant tumors comprised squamous cell carcinoma 8 (5.5%), Burkitt's lymphoma 5(3.4%), osteogenic sarcoma 5(3.4%) and rhabdomyosarcoma 4 (2.7%). Table 1 shows the age distribution of 146 patients seen over 11 years in Calabar, Nigeria. The peak age of ameloblastoma was the fourth decade while that of fibrous dysplasia and ossifying fibroma were the second and third decade respectively. The age distribution of malignant tumors between pediatric and adult population was significant (X 2 =457.33, df=108, p=0.001) ( Table  1 ). This shows that certain malignant tumors are age specific. Thus, childhood malignant conditions were observed to peak during the first decade and squamous cell carcinomas were seen in the sixth and seventh decades of life (Table 1) . The gender distribution of tumors and tumor-like lesions in 146 patients seen over the period of study is shown in Table 2 . Majority of the maxillofacial tumors had predominant male distribution except for pyogenic granuloma, where female dominance was observed. The male to female ratios for benign and malignant tumors were 1:1.8 and 1:3.4 respectively (Table 2). Table 3 shows the distribution of lesions according to site and main presenting complaints in 146 patients seen over 11 years period. Overall the tumors were distributed in an approximate ratio of 3:1 between the mandible and maxilla. Among the benign lesions predilection for the mandible was observed for ameloblastoma, keratocystic odontogenic tumor, dentigerous cyst and ossifying fibroma in this series. There was an equitable distribution of malignant tumors between mandible and maxilla with an approximate ratio of 1:1 (Table 3) . Across the series jaw swellings were the most common presentation (98, 67.1%), followed by pain (23, 15.9) , toothache (12, 8 .2%) and loose teeth (11, 7.5%) ( Table 3) . Half of the patients with malignant tumors presented with pain while only 9.7% of patients with benign tumors presented with pain. Ulceration which is commonly seen in malignant lesions especially squamous cell carcinoma was not observed. The duration of symptoms on presentation ranged from 1 month to 96 months (mean 23.32 +15.72) and this was not different for malignant or benign tumors (P=0.886). 
Discussion
The observed late presentation of facial and intraoral swellings, often gross and disfiguring was similar to published reports. 2, 3 Benign lesions was the most common presentation (86.3%) while malignant lesions accounted for 13.7%. This sharply contrast previous reports from Nigeria and other parts of the world where benign lesions were only slightly more than malignant lesions in their distribution. The reason for this difference may be explained by the exclusion of cystic and reactive lesions from the previous studies. 2, [12] [13] [14] Generally, studies from the developed countries reports higher proportion of malignant jaw lesions than benign lesions when compared to reports from Africa. This observed difference may be explained in terms of relatively lower life expectancy among Africans compared to their Western counterparts. 15 Overall, ameloblastoma was the most predominant lesion (36.3%) and it accounted for 53 (80.3%) out of the 66 odontogenic tumors (OT) observed in this series. The observed prevalence of 80.3%, while comparable to the 83.3% obtained by Adebiyi et al. from Lagos, Nigeria 16 is much higher than results of similar studies from Nigeria. 2, 17, 18 Our observed prevalence of ameloblastoma (n=53; 80.3%) in our 11 year study period was comparable to that of Adebayo et al. 10 (n=12; 80%) recorded in a period of 5 years from the same geopolitical zone in southern Nigeria. One reason adduced for the relatively high frequency of occurrence is the heterogeneous epithelial origin of ameloblastoma. 19, 20 The relatively high prevalence obtained for ameloblastoma could also be due to "harvesting phenomenon" as defined by Anand et al. 21 Although the university of Calabar teaching hospital has been in existence for over 3 decades, active oral and maxillofacial services commenced only a decade and a half ago. Our study period appears to coincide with the time when patients with orofacial tumors, including cystic lesions, were referred to our centre because of availability of such services. Apart from the suggested high predilection of ameloblastoma for West Africans, 22 it is most likely that the relatively high prevalence of ameloblastoma observed in the present study may also be due to the small size of odontogenic tumors recorded among our study population. This assertion is strenghtened when our observed prevalence (80.3% out of 66 OT) is compared with those of Arotiba et al 17 (16% out of 415 OT), Ladeinde et al 18 (63% out of 319 OT) and Odukoya 25 (58.5% out of 289 OT). The predilection for the mandible as well as the age and gender distribution is consistent with reports in the literature. 16, 23, 24 In line with the recent WHO criteria 11 odontogenic keratocysts categorized as odontogenic tumor (Keratocystic odontogenic tumor ( KCOT) was the next most common lesion (8.2%) after ameloblastoma across the series. This is contrary to the findings in some studies where KCOT were reported as the most prevalent OT in studies that used the 2005 WHO classification. 25, 26 Expectedly, inclusion of this cystic lesion as OT slightly (8.2%) increased the overall proportion of OT in the series but it was much lower than the almost 50.0% increment observed by Servato et al. in a recent Brazilian study. 26 The prevalence of odontogenic cysts has been shown to be in the range of 0.8-49.0%. 22, 28, 29 We observed a prevalence of 11.0% in a period of 11 years. Our relatively lower prevalence value obtained for odontogenic cyst in this study may be due to exclusion of odontogenic keratocyst which was grouped under odontogenic tumor in the present analysis. Dentigerous and radicular cysts had peak age distribution of second and third decade respectively. All the dentigerous cysts observed in this series occurred in the mandible while the maxilla was the predominant site of occurrence for radicular cyst. The age and site distribution of these cystic lesions was consistent with earlier reports. 28, 30 Fibro-osseous lesions, distributed as fibrous dysplasia (6.2%) and ossifying fibroma (6.8%) collectively accounted for 13.0%. Fibro-osseous lesions occurred over the second to the sixth decade with peak age of second and third decade for fibrous dysplasia and ossifying fibroma respectively. The often observed female predominance 31, 32 and predilection for the maxilla 31, 32 reported in the literature were not observed in the present study. The male to female ratio of 1:1.4 obtained in the present study agreed with the result of an earlier study from Nigeria. 33 There was no significant difference in terms of occurrence in the mandible 10 (6.8%) and maxilla 9 (6.2%) in this series.
Pyogenic granuloma is a relatively common tumor-like lesion which includes 3.81% to 7% of all biopsy results of oral cavity lesions. 34, 35 The etiology of pyogenic granuloma is unknown, but it has been linked to trauma due to chronic irritation from calculus, faulty appliances or restorations. 35 The prevalence of 7.5% observed in the present study supports previous reports. 34, 35 Similarly, the age of occurrence, female predominance and preference for the maxilla observed in this study lend credence to published reports. 33, 34 Other less frequently observed benign lesions in the maxillofacial complex included giant cell granuloma, osteoma and pleomorphic adenoma presenting as parotid swelling. That only 2 (1.4%) cases of salivary gland tumors were seen in the eleven year period of study was not surprising. In our institution various surgical subspecialties including general surgery, otorhinolaryngology and maxillofacial surgery are involved in the management of salivary gland tumors especially those that involve the major glands. This probably explains the low prevalence of salivary gland tumors observed in the present study.
The observed prevalence of 13.7% for malignant tumors while comparable to other reports 13, 36 is much lower than the 67.3% reported from East Africa by Kamulegeya and Kalmyanyama.
14 The relatively lower figure for malignant tumors obtained in the present study and other similar studies may be due to inclusion of cysts and other tumor-like lesions in the data collection. Squamous cell carcinoma (5.5%), the most common malignant histological diagnosis constituted about 36.4% of the malignant lesions in this series. This prevalence is lower than the 57.7% reported by Adekeye et al 15 from a review of intraoral carcinomas in Northern Nigeria. This difference may be due to climatic differences. Our institution is within the rain forest belt of Nigeria with lower levels of sunshine compared to the dry savannah of the northern part of the country. This probably explains why lip cancer was not observed among our cases. Earlier studies from Nigeria observed frequent occurrences of oral cancers in lower age groups. 15, 37 The observed peak age of occurrence of 6 th and 7 th decades agreed with reports from the Western world. 7, 8 All the squamous cell carcinoma were observed in patients over 50 years of age. The average life expectancy in Nigeria was previously estimated at 40 years. 15 The result of our study tends to lend credence to a recent World Health Statistics Report 38 . The observed peak age of occurrence could also be explained by the small size of oral cancers (8) which were distributed within the 6 th and 7 th decades only.
Childhood malignant jaw tumors, represented by Burkitt's lymphoma (3.4%) and rhabdomyosarcoma (2.7%) and constituting 22.7% and 18.2% respectively of all malignant lesions, were observed to peak within the first decade of life, which agreed with previous reports. 39, 40 While the gender distribution of Burkitt's lymphoma is in support of published reports, 3,9 the observed slight predilection for the maxilla contrasts with other reports that noted higher occurrence in the mandible. 3, 9, 14 The results of this study support the observed female predominance for rhabdomyosarcoma 5 but differs from that of a study from Germany. 41 Other malignant jaw tumors such as Hodgkin and nonHodgkin lymphomas, malignant salivary gland tumors, neural and vascular lesions were not observed in this series.
Conclusion
The epidemiology of oral and maxillofacial tumors observed in this study, with the exception of squamous cell carcinoma, is similar to previous reports from this part of the globe. Our observed age of occurrence of squamous cell carcinoma is higher than previous reports from Nigeria. Late presentation still remains the main challenging factor in the early detection and management of maxillofacial tumors. More awareness campaign is necessary, especially at the primary health care level, to educate the populace on the need for early presentation at treatment centers.
